| Objective:Through systematic clinical research of jingfangsandou united states of TCM ion import therapy was introduced to the HSP of the children's skin.To determine clinical efficacy,and based on the theory of clinical meidicine.Method:Into 60 skin HSP children,and randomly divided into two groups.To collect their ages,the clinical performance,the onset of the disease,lab resaults,medical examiner.Results:1.All of the 60 cases appared purpura,37 of them,23 girls.The oldest is14 and the youngest is 3.The procedure longest for four years,three days of the shortest.2.Durning observe,we can deserve that the Xianzisan ions import children's Henoch-Schonlein purpura is aways an 100% efficiency.After conmpare with the differences of the treatment symptoms score,the resaults it is statistically meaningful(P<0.05).3.Security analysis:During the entire treatment process,there Was no adverse reaction.This results instuctions that Jingfangsandou combine Xianzisan ions import therapy children's Henoch-Schonlein purpura is safe.4.The Henoch-Schonlein purpura of the incidenc of kidney damage is 80% and100%,After Jingfangsandou combine Xianzisan ions import therapy,the renal damage rate is 46.7% and the people of who has the renal damage is 14.And the jinfangsandou therapy is 26,the rate is 86.7%.The time of kindney damage's occuras is aways between the first and three months.Compared with the differences,it is statistically meaningful(P<0.05).Conclusion:1.The Henoch-Schonlein purpura children is male patients are more female than woman,and the average age distribution is 6 to 12 years old.2.The Jingfangsandou combine Xianzisan ions import therapy the Henoch-Schonlein purpura is very effective,and the drug has yet to appear in clinical use.3.The Jingfangsandou combine Xianzisan ions import therapy the Henoch-Schonlein can shorten the procedure and delay the time of nephritis,reduce kindney damage,improve the prognosis. |
PDF Full Text Request